Search Results
Search results for "GPCR Research"
Results found for "GPCR Research"
- C3aR plays both sides in regulating resistance to bacterial infections
Specifically, previous research has identified mechanistically distinct and cell type–specific roles Read more at the source #DrGPCR #GPCR #IndustryNews
- Case Report of a Juvenile Patient with Autism Spectrum Disorder with a Novel Combination of Copy...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Read more at the source #DrGPCR #GPCR #IndustryNews
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
Read more at the source #DrGPCR #GPCR #IndustryNews
- When January Looks Different by March: Orthosteric vs. Allosteric Insights from Our Latest AMA
recent live Ask Me Anything (AMA) session, where members brought forward active questions from their GPCR submit questions in advance to: terry@drgpcr.org Distinguishing Orthosteric vs Allosteric Mechanisms in GPCR for interpreting Schild plot deviations and probe dependence Operational practices that strengthen GPCR GPCR systems are sensitive and context-dependent. Forty years of pharmacological expertise — organized into a year-round learning framework for serious GPCR
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
August 2022 "Abstract Sigma receptor is a transmembrane non-GPCR protein expressed mainly in the endoplasmic Read more at the source #DrGPCR #GPCR #IndustryNews
- Immunomodulatory Role of Neuropeptides in the Cornea
As research in this area expands, further insights are made into the role of neuropeptides and their Read more at the source #DrGPCR #GPCR #IndustryNews
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs Vice-President Drug Discovery, will present Orion’s novel technology for targeting undrugged peptidergic GPCRs discovery platform, one of the fastest drug discovery solutions in the industry for targeting peptidergic GPCRs antagonist, OB-004, demonstrating the ability of this powerful platform to rapidly identify best-in-class GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- 2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany
Read more at the source #DrGPCR #GPCR #IndustryNews
- C1-inhibitor influence on platelet activation by thrombin receptors agonists
Read more at the source #DrGPCR #GPCR #IndustryNews
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
GPCRs couple, decouple, isomerize, deplete tracers, and shift apparent affinity depending on stoichiometry ll gain: Why saturation and displacement assays fail when protein stoichiometry shifts How two-stage GPCR Complex Two-Stage Biology Behind Orthosteric Binding GPCR pharmacology rarely follows the neat Langmuir Clues that point to true multiple-site binding rather than two-stage GPCR biology: Disrupting G protein leaders who need credible guidance fast, the Corner brings clarity to the complexities shaping modern GPCR
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
September 2022 "Research on cancer therapies focuses on processes such as angiogenesis, cell signaling Read more at the source #DrGPCR #GPCR #IndustryNews
- Naggie and Rajagopal Elected Members of American Society for Clinical Investigation
" Read more at the source #DrGPCR #GPCR #IndustryNews
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
Read more at the source #DrGPCR #GPCR #IndustryNews
- ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
media at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) the same day. " Read more at the source #DrGPCR #GPCR
- Discovery On Target, October 17-20, 2022, Boston, USA
Read more at the source #DrGPCR #GPCR #IndustryNews
- Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
Read more at the source #DrGPCR #GPCR #IndustryNews
- Chemerin Forms: Their Generation and Activity
Read more at the source #DrGPCR #GPCR #IndustryNews
- CD28 and chemokine receptors: Signalling amplifiers at the immunological synapse
Read more at the source #DrGPCR #GPCR #IndustryNews
- Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI
Prior to this, Professor Deane was Deputy Executive Chair of the Engineering and Physical Sciences Research Council at UK Research and Innovation (UKRI). Read more at the source #DrGPCR #GPCR #IndustryNews
- Jan Steyaert Named 2022 Jacob and Louise Gabbay Award Winner
This award recognizes the combination of Steyaert’s fundamental research and his ability to apply the research to the development of therapeutic technologies. Steyaert bridged fundamental high-impact research in biomedical sciences with the mechanistic understanding Read more at the source #DrGPCR #GPCR #IndustryNews
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
Read more at the source #DrGPCR #GPCR #IndustryNews
- Identification of hub genes in the subacute spinal cord injury in rats
Finally, the relative mRNA expression level of central genes was verified by RT-PCR." Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Reports Second Quarter 2022 Results and Provides Business Update
Read more at the source #DrGPCR #GPCR #IndustryNews
- A new Kunitz-type snake toxin family associated with an original mode of interaction with the...
antagonist of the arginine-vasopressin V2 receptor (V2R) and the only unique Kunitz-type peptide active on a GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Read more at the source #DrGPCR #GPCR #IndustryNews
- Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
Read more at the source #DrGPCR #GPCR #IndustryNews
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
Read more at the source #DrGPCR #GPCR #IndustryNews
